Does HUMAN C1-ESTERASE INHIBITOR Cause Hospitalisation? 161 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 161 reports of Hospitalisation have been filed in association with HUMAN C1-ESTERASE INHIBITOR (Cinryze). This represents 1.1% of all adverse event reports for HUMAN C1-ESTERASE INHIBITOR.
161
Reports of Hospitalisation with HUMAN C1-ESTERASE INHIBITOR
1.1%
of all HUMAN C1-ESTERASE INHIBITOR reports
3
Deaths
159
Hospitalizations
How Dangerous Is Hospitalisation From HUMAN C1-ESTERASE INHIBITOR?
Of the 161 reports, 3 (1.9%) resulted in death, 159 (98.8%) required hospitalization, and 12 (7.5%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HUMAN C1-ESTERASE INHIBITOR. However, 161 reports have been filed with the FAERS database.
What Other Side Effects Does HUMAN C1-ESTERASE INHIBITOR Cause?
Hereditary angioedema (5,572)
No adverse event (1,660)
Off label use (1,614)
Drug ineffective (1,426)
Intentional product use issue (1,117)
Product use in unapproved indication (1,003)
Weight increased (897)
Maternal exposure during pregnancy (869)
Pain (822)
Condition aggravated (775)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which HUMAN C1-ESTERASE INHIBITOR Alternatives Have Lower Hospitalisation Risk?
HUMAN C1-ESTERASE INHIBITOR vs HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX
HUMAN C1-ESTERASE INHIBITOR vs HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
HUMAN C1-ESTERASE INHIBITOR vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G
HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE